May 27, 2020
Amivas (US), LLC Announces FDA Approval of Artesunate for Injection for Treatment of Severe Malaria
May 26, 2020
FDA Approves Only Drug in U.S. to Treat Severe Malaria
May 04, 2020
Global Anti-Malarial Drugs Market (by Drug Type, Anti-Malarial Activity, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
Jan 31, 2019
$830 Bn Artemisinin Combination Market - Global Outlook & Forecast Report 2017-2026
Dec 06, 2018
Worcester Polytechnic Institute Biologist Part of Clinical Trial Showing Tea Made from Artemisia Outperformed Drug against Tropical Disease
Jun 28, 2018
SwRI receives grant to reduce the cost of current malaria treatment
Jun 19, 2018
Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria
Jun 12, 2018
Data Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
Jun 07, 2018
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
Apr 22, 2018
Juntendo University Research: Malaria in Africa is Developing Resistance to Drugs
Nov 06, 2017
Artemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria
May 30, 2017
Eisai Enters into a New Joint Research Agreement with the Broad Institute to Develop an Antimalarial Medicine